Overview
Ludmila Martin is an Oncologist in Gig Harbor, Washington. Dr. Martin is rated as an Experienced provider by MediFind in the treatment of Mesenchymoma. Her top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, Lynch Syndrome, and Neuroendocrine Tumor.
Her clinical research consists of co-authoring 19 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- EPO
- HMO
- HMO
- MANAGED MEDICAID PLAN
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
Accepted plan types not found. Please verify directly with the provider.
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- PPO
- EPO
- HMO
- PPO
- PPO
- EPO
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
11511 Canterwood Blvd, Suite 45, Gig Harbor, WA 98332
34509 9th Ave S, Suite 107, Federal Way, WA 98003
1624 S I St, Tacoma, WA 98405
Additional Areas of Focus
Dr. Martin has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
The Association Of University Physicians
Elizabeth Loggers is an Oncologist and a Hematologist in Seattle, Washington. Dr. Loggers is rated as an Elite provider by MediFind in the treatment of Mesenchymoma. Her top areas of expertise are Adult Soft Tissue Sarcoma, Liposarcoma, Epithelioid Sarcoma, Angiosarcoma, and Liver Embolization. Dr. Loggers is currently accepting new patients.
Kinsey Mccormick is an Oncologist in Seattle, Washington. Dr. Mccormick is rated as a Distinguished provider by MediFind in the treatment of Mesenchymoma. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Angiosarcoma, and Inflammatory Breast Cancer. Dr. Mccormick is currently accepting new patients.
Proliance Orthopaedics & Sports Medicine
James D. Bruckner, MD, is a board-certified orthopedic surgeon. His clinical interests include the reconstruction and preservation of the hip and knee, as well as orthopedic oncology, including adult and pediatric musculoskeletal tumor surgery. Dr. Bruckner completed both his undergraduate and graduate work at Creighton University in Omaha, Nebraska, graduating summa cum laude with a Bachelor of Mathematics and earning magna cum laude honors from the medical school. He completed his residency and served as a clinical instructor in orthopedics with the U.S. Navy. His fellowship training was completed at Seattle at Children's Hospital and the University of Washington. While at U.W., he was an associate professor in the Department of Orthopaedics, served as Director of the hip and knee replacement service and developed the total-joint fellowship program. Dr. Bruckner has received numerous honors, awards, and peer recognition. He was Chairman of the Overlake Hospital Department of Orthopaedics from 2006 through 2010. He has three grown sons, is an avid gardener and musician, and enjoys both skiing and wakesurfing. Dr. Bruckner is rated as an Advanced provider by MediFind in the treatment of Mesenchymoma. His top areas of expertise are Osteoarthritis, Bone Tumor, Undifferentiated Pleomorphic Sarcoma, Knee Replacement, and Hip Replacement.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- AgranulocytosisDr. Martin isDistinguished. Learn about Agranulocytosis.
- Chronic Familial NeutropeniaDr. Martin isDistinguished. Learn about Chronic Familial Neutropenia.
- Colorectal CancerDr. Martin isDistinguished. Learn about Colorectal Cancer.
- Familial Colorectal CancerDr. Martin isDistinguished. Learn about Familial Colorectal Cancer.
- Hemangioma Thrombocytopenia SyndromeDr. Martin isDistinguished. Learn about Hemangioma Thrombocytopenia Syndrome.
- Lung CancerDr. Martin isDistinguished. Learn about Lung Cancer.
- Advanced
- Ampullary CancerDr. Martin isAdvanced. Learn about Ampullary Cancer.
- Anal CancerDr. Martin isAdvanced. Learn about Anal Cancer.
- AngiosarcomaDr. Martin isAdvanced. Learn about Angiosarcoma.
- Appendix CancerDr. Martin isAdvanced. Learn about Appendix Cancer.
- Breast CancerDr. Martin isAdvanced. Learn about Breast Cancer.
- Cholangiocarcinoma (Bile Duct Cancer)
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Dr. Martin isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Monoblastic Leukemia (AmoL)Dr. Martin isExperienced. Learn about Acute Monoblastic Leukemia (AmoL).
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Martin isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Acute Promyelocytic LeukemiaDr. Martin isExperienced. Learn about Acute Promyelocytic Leukemia.